Products for Research Use Only
RegisterLogin

Letaplimab

CAT: 0804-HY-P99700-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99700-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Letaplimab (IBI-188) is a human IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis[1].
CAS Number
2283356-07-8
Product Name Alternative
IBI-188
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/letaplimab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Letaplimab]
Molecular Weight
(142.38 kDa)
References & Citations
[1]Miao Miao, et al. A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome. MYELODYSPLASTIC SYNDROMES-CLINICAL AND EPIDEMIOLOGICAL NOVEMBER 15, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T78323-01Letaplimab
GTR18398735-01Letaplimab Antibody
048065CD47 (letaplimab) discontinued
A2824-1mg*25Letaplimab (Anti-CD47)
E55B0799Letaplimab (Reference antibody)
WA3069Research Grade Letaplimab
21-925Letaplimab - Research Grade Biosimilar
ICH5251-5mgLetaplimab Biosimilar - Research Grade
GTR18780644-01(Letaplimab) Biosimilar Reference Antibody
F1166-50Anti-CD47 Antibody (Letaplimab)

Popular Products